We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Experimental Ebola Vaccine Safe, Prompts Immune Response

Results from US government-sponsored phase 1 trial of VSV vaccine reported.
News

$2.1 Million Grant Targets Antibiotic Resistance

Grant to develop small-molecules that counter antibiotic resistance in Gram-negative bacteria.
News

IUPUI Chemist Earns Grant to Improve Drug Screening in Forensics

$273,826 award to improve the speed and accuracy of mass spectrometry for detecting drugs and poisons.
News

Broad Institute of MIT and Harvard and Bayer Healthcare Expand their Partnership

Collaboration to develop therapies for cardiovascular disease.
News

Saccharin Shows Promise as Cancer Inhibitor

Researchers have found that the artificial sweetener can inhibit cancer cell growth.
News

BioTek Nominated for Department of Defense’s Top Employer Award

BioTek Instruments been nominated for the 2015 Secretary of Defense Employer Support Freedom Award by the Employer Support of the Guard and Reserve (ESGR), a Department of Defense (DoD) office.
News

BioLineRx Reports Year End 2014 Financial Results

Top-line results from Phase 2a clinical study of BL-8040 expected in the second half of 2015.
News

Luminex Begins Clinical Trials for ARIES® System and ARIES® HSV 1&2 Assay

Company plans to seek both FDA clearance and CE IVD marking this year.
News

Vanderbilt and Pittsburgh to Lead New Center to Identify Toxic Chemicals

VPROMPT will receive $6 million to develop toxicity test procedures based on three-dimensional human cell cultures.
News

apceth Initiates Phase II Clinical Trial for Pioneering Engineered Cell Therapy

Successfully completed Phase I clinical study and regulatory approval enable world’s first genetically-engineered cell therapy to enter Phase II.
Advertisement